Li P, Wang Q, He Y, Yang C, Zhang Z, Liu Z
Emerg Microbes Infect. 2022; 12(1):e2136538.
PMID: 36239345
PMC: 9980405.
DOI: 10.1080/22221751.2022.2136538.
Boliar S, Murphy M, Tran T, Carnathan D, Armstrong W, Silvestri G
J Virol. 2012; 86(15):8031-40.
PMID: 22623771
PMC: 3421653.
DOI: 10.1128/JVI.00771-12.
Kling H, Shipley T, Norris K
Comp Med. 2011; 61(3):269-77.
PMID: 21819698
PMC: 3123761.
Chen K, Cerutti A
Immunol Rev. 2010; 237(1):160-79.
PMID: 20727035
PMC: 3048779.
DOI: 10.1111/j.1600-065X.2010.00929.x.
Epeldegui M, Thapa D, de la Cruz J, Kitchen S, Zack J, Martinez-Maza O
PLoS One. 2010; 5(7):e11448.
PMID: 20625427
PMC: 2897846.
DOI: 10.1371/journal.pone.0011448.
Immunoglobulin D: properties, measurement, and clinical relevance.
Vladutiu A
Clin Diagn Lab Immunol. 2000; 7(2):131-40.
PMID: 10702483
PMC: 95839.
DOI: 10.1128/CDLI.7.2.131-140.2000.
Differential regulation of the antibody responses to Gag and Env proteins of human immunodeficiency virus type 1.
Binley J, Klasse P, Cao Y, Jones I, Markowitz M, Ho D
J Virol. 1997; 71(4):2799-809.
PMID: 9060635
PMC: 191404.
DOI: 10.1128/JVI.71.4.2799-2809.1997.
Immunoglobulin and complement complexes in blood following infection with human immunodeficiency virus type 1.
Peng X, Wainberg M, Tao Y, Brenner B
Clin Diagn Lab Immunol. 1996; 3(1):128-31.
PMID: 8770516
PMC: 170259.
DOI: 10.1128/cdli.3.1.128-131.1996.
Cerebrospinal fluid antiganglioside antibodies in patients with AIDS.
Sorice M, Griggi T, Circella A, Nicodemo G, Ciardi M, Mastroianni C
Infection. 1995; 23(5):288-91.
PMID: 8557387
DOI: 10.1007/BF01716288.
Defective IL-6 secretion in HIV-infected haemophilia patients.
Weimer R, Zipperle S, Daniel V, Zimmermann R, Opelz G
Clin Exp Immunol. 1993; 91(2):249-56.
PMID: 8428391
PMC: 1554675.
DOI: 10.1111/j.1365-2249.1993.tb05891.x.
Phenotypical and functional evaluation of CD8+/S6F1+ T lymphocytes in haemophiliac individuals with HIV-1 infection.
Cavallin F, TRALDI A, Zambello R
Clin Exp Immunol. 1993; 93(1):51-5.
PMID: 8324903
PMC: 1554750.
DOI: 10.1111/j.1365-2249.1993.tb06496.x.
Markers predicting progression of human immunodeficiency virus-related disease.
Tsoukas C, Bernard N
Clin Microbiol Rev. 1994; 7(1):14-28.
PMID: 8118788
PMC: 358303.
DOI: 10.1128/CMR.7.1.14.
Interaction between gamma delta T cells and B cells regulating IgG production.
Hacker G, Adam S, Wagner H
Immunology. 1995; 84(1):105-10.
PMID: 7890294
PMC: 1415197.
Epitopes for natural antibodies of human immunodeficiency virus (HIV)-negative (normal) and HIV-positive sera are coincident with two key functional sequences of HIV Tat protein.
Rodman T, To S, Hashish H, Manchester K
Proc Natl Acad Sci U S A. 1993; 90(16):7719-23.
PMID: 7689227
PMC: 47214.
DOI: 10.1073/pnas.90.16.7719.
In vitro influence of Mycoplasma penetrans on activation of peripheral T lymphocytes from healthy donors or human immunodeficiency virus-infected individuals.
Sasaki Y, Blanchard A, Watson H, Garcia S, Dulioust A, Montagnier L
Infect Immun. 1995; 63(11):4277-83.
PMID: 7591058
PMC: 173607.
DOI: 10.1128/iai.63.11.4277-4283.1995.
Generation of human monoclonal antibodies to human immunodeficiency virus.
Gorny M, Gianakakos V, Sharpe S, Zolla-Pazner S
Proc Natl Acad Sci U S A. 1989; 86(5):1624-8.
PMID: 2922401
PMC: 286751.
DOI: 10.1073/pnas.86.5.1624.
IgD production and other lymphocyte functions in HIV infection: immaturity and activation of B cells at different clinical stages.
Rogers L, Forster S, Pinching A
Clin Exp Immunol. 1989; 75(1):7-11.
PMID: 2784730
PMC: 1541852.
Polyclonal B-cell activation reveals antibodies against human immunodeficiency virus type 1 (HIV-1) in HIV-1-seronegative individuals.
Slade B, Powell J, Villinger F, De B, Folks T, McClure H
Proc Natl Acad Sci U S A. 1990; 87(10):3972-6.
PMID: 2111024
PMC: 54026.
DOI: 10.1073/pnas.87.10.3972.
Immunoglobulin G subclass preference of intrathecally produced HIV-specific oligoclonal antibodies.
Kaiser R, Dorries R, Ruf B, POHLE H, Martin R, Ter Meulen V
J Neurol. 1991; 238(6):331-6.
PMID: 1940985
DOI: 10.1007/BF00315333.
Human immunodeficiency virus infection induces both polyclonal and virus-specific B cell activation.
Shirai A, Cosentino M, Klinman D
J Clin Invest. 1992; 89(2):561-6.
PMID: 1737846
PMC: 442888.
DOI: 10.1172/JCI115621.